TransTech Pharma, Inc. Selects GeneData AG To Enhance High Throughput Screening Analysis

Genedata announces that TransTech Pharma has signed a multi-year license for high throughput screening analysis software Genedata Screener®. Scientists at TransTech Pharma will use Screener to enhance their efforts to develop small molecules as therapeutics for treating human diseases.
MORE ON THIS TOPIC